|
Español
English
|
Dadun >
Browsing by Author Diez, J. (Javier)
Showing results 108 to 127 of 201
| Issue Date | Title | Author(s) | | 2004 | Kidney function and cardiovascular disease. Physiopathologic basis of the association | Diez, J. (Javier) |
| Sep-2002 | Leptin Inhibits Angiotensin II-Induced Intracellular Calcium Increase and Vasoconstriction in the Rat Aorta | Fortuño, A. (A.); Rodriguez, A. (Amaia); Gomez-Ambrosi, J. (Javier); Muñiz, P. (Paula); Salvador, J. (Javier); Diez, J. (Javier); Frühbeck, G. (Gema) |
| 2002 | Losartan-dependent regression of myocardial fibrosis is associated with reduction of left ventricular chamber stiffness in hypertensive patients | Diez, J. (Javier); Querejeta, R. (Ramón); Lopez, B. (Begoña); Gonzalez, A. (Arantxa); Larman, M. (Mariano); Martinez-Ubago, J.L. (José L.) |
| 1999 | Losartan inhibits the post-transcriptional synthesis of collagen type I and reverses left ventricular fibrosis in spontaneously hypertensive rats | Varo, N. (Nerea); Etayo, J.C. (Juan Carlos); Zalba, G. (Guillermo); Beaumont, J. (Javier); Iraburu, M.J. (María J.); Montiel-Duarte, C. (Cristina); Gil, M.J. (María José); Monreal, I. (Ignacio); Diez, J. (Javier) |
| 2009 | Losartan metabolite EXP3179 blocks NADPH oxidase-mediated superoxide production by inhibiting protein kinase C: potential clinical implications in hypertension | Fortuño, A. (A.); Bidegain, J. (J.); Robador, P.A. (Pablo A.); Hermida, J. (José); Lopez-Sagaseta, J. (Jacinto); Beloqui, O. (Óscar); Diez, J. (Javier); Zalba, G. (Guillermo) |
| 1999 | Los retos de la hipertensión arterial en el siglo XXI | Diez, J. (Javier); Laviades, C. (Concepción) |
| 2007 | Loss of myocardial LIF receptor in experimental heart failure reduces cardiotrophin-1 cytoprotection. A role for neurohumoral agonists? | Lopez, N. (Natalia); Varo, N. (Nerea); Diez, J. (Javier); Fortuño, M.A. (María Antonia) |
| 2008 | Mechanical dyssynchrony: another mechanism of left ventricular dysfunction in hypertension? | Diez, J. (Javier); Garcia-Bolao, I. (Ignacio); Barba, J. (Joaquín) |
| 2005 | Mechanisms of disease: pathologic structural remodeling is more than adaptive hypertrophy in hypertensive heart disease | Diez, J. (Javier); Gonzalez, A. (Arantxa); Lopez, B. (Begoña); Querejeta, R. (Ramón) |
| 2000 | Mechanisms of increased susceptibility to angiotensin II-induced apoptosis in ventricular cardiomyocytes of spontaneously hypertensive rats | Ravassa, S. (Susana); Fortuño, M.A. (María Antonia); Gonzalez, A. (Arantxa); Lopez, B. (Begoña); Zalba, G. (Guillermo); Fortuño, A. (A.); Diez, J. (Javier) |
| 2008 | Molecular mechanisms of atherosclerosis in metabolic syndrome: role of reduced IRS2-dependent signaling | Gonzalez-Navarro, H. (Herminia); Vinue, A. (Angela); Vila-Caballer, M. (Marian); Fortuño, A. (A.); Beloqui, O. (Óscar); Zalba, G. (Guillermo); Burks, D. (Deborah); Diez, J. (Javier); Andres, V. (Vicente) |
| 1997 | Monitoring fibrillar collagen turnover in hypertensive heart disease | Diez, J. (Javier); Laviades, C. (Concepción) |
| 2005 | Monocyte cyclooxygenase-2 overactivity: a new marker of subclinical atherosclerosis in asymptomatic subjects with cardiovascular risk factors? | Beloqui, O. (Óscar); Paramo, J.A. (José Antonio); Orbe, J. (Josune); Benito, A. (Alberto); Colina, I. (Inmaculada); Monasterio, A. (Alberto); Diez, J. (Javier) |
| 2007 | Myocardial fibrosis and diastolic dysfunction in patients with hypertension: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) | Müller-Brunotte, R. (Richard); Kahan, T. (Thomas); Lopez, B. (Begoña); Edner, M. (Magnus); Gonzalez, A. (Arantxa); Diez, J. (Javier); Malmqvist, K. (Karin) |
| 2010 | Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy | Ho, C.Y. (Carolyn Y.); Lopez, B. (Begoña); Coelho-Filho, O.R. (Otavio R.); Lakdawala, N.K. (Neal K.); Cirino, A.L. (Alison L.); Jarolim, P. (Petr); Kwong, R. (Raymond); Gonzalez, A. (Arantxa); Colan, S.D. (Steven D.); Seidman, J.G. (J.G.); Diez, J. (Javier); Seidman, C.E. (Christine E.) |
| 2006 | Myocardial fibrosis, impaired coronary hemodynamics, and biventricular dysfunction in salt-loaded SHR | Varagic, J. (Jasmina); Frohlich, E.D. (Edward D.); Diez, J. (Javier); Susic, D. (Dinko); Ahn, J. (Jwari); Gonzalez, A. (Arantxa); Lopez, B. (Begoña) |
| 2002 | Myocardial fibrosis in arterial hypertension | Gonzalez, A. (Arantxa); Lopez, B. (Begoña); Diez, J. (Javier) |
| 2008 | Myocardial fibrosis in chronic kidney disease: potential benefits of torasemide | Lopez, B. (Begoña); Gonzalez, A. (Arantxa); Hermida, N. (Nerea); Laviades, C. (Concepción); Diez, J. (Javier) |
| 2010 | Myocardial remodeling after infarction: the role of myofibroblasts | van-den-Borne, S.W.M. (Susanne W.M.); Diez, J. (Javier); Blankesteijn, W.M. (W. Matthijs); Verjans, J. (Johan); Hofstra, L. (Leo); Narula, J. (Jagat) |
| 2001 | Myocardial Response to Biomechanical Stress | Diez, J. (Javier); Lopez, B. (Begoña); Gonzalez, A. (Arantxa); Ardanaz, N. (Noelia); Fortuño, A. (A.) |
Showing results 108 to 127 of 201
|
